Other OTC - Delayed Quote • USD
Amarantus BioScience Holdings, Inc. (AMBS)
As of April 23 at 1:20 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| COMMISSIONG GERALD Chief Executive Officer | Purchase | Apr 8, 2015 | 8,259,570 |
| FARRELL ROBERT EDWARD Chief Financial Officer | Purchase | Apr 9, 2015 | 333,333 |
| HARRIS ROBERT LEWIS Director | Purchase | Dec 2, 2015 | 96,070 |
| RUBINFELD JOSEPH Director | Stock Award(Grant) | Dec 8, 2014 | 2,056,500 |
Related Tickers
BIOAF Bioasis Technologies Inc.
0.0040
-33.33%
296.SG CytoDyn Inc
0.1370
-0.72%
RVPHW Reviva Pharmaceuticals Holdings, Inc.
0.5400
+22.06%
CWBR CohBar, Inc.
0.9004
0.00%
NYMXF Nymox Pharmaceutical Corporation
0.3250
+8.33%
MACK Merrimack Pharmaceuticals, Inc.
14.73
0.00%
ACOGF Alpha Cognition Inc.
0.4880
-1.42%
COEP Coeptis Therapeutics Holdings, Inc.
0.3323
-0.81%
NLSP NLS Pharmaceutics Ltd.
0.1290
-3.15%
ARDS Aridis Pharmaceuticals, Inc.
0.0605
-4.58%